These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8758135)

  • 1. Uncooked cornstarch--efficacy in type I glycogenosis.
    Lee PJ; Dixon MA; Leonard JV
    Arch Dis Child; 1996 Jun; 74(6):546-7. PubMed ID: 8758135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral cornstarch therapy: is persorption harmless?
    Gitzelmann R; Spycher MA
    Eur J Pediatr; 1993 Jul; 152(7):592-4. PubMed ID: 8354319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A triple-blinded crossover study to evaluate the short-term safety of sweet manioc starch for the treatment of glycogen storage disease type Ia.
    Monteiro VCL; de Oliveira BM; Dos Santos BB; Sperb-Ludwig F; Refosco LF; Nalin T; Derks TGJ; Moura de Souza CF; Schwartz IVD
    Orphanet J Rare Dis; 2021 Jun; 16(1):254. PubMed ID: 34082801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type I glycogenosis with renal tubular dysfunction (presentation of two cases).
    Yüce A; Coşkun T; Koçak N; Ozsoylu S; Ozalp I; Göğüş S
    Turk J Pediatr; 1993; 35(3):201-4. PubMed ID: 8165754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis.
    Shah KK; O'Dell SD
    J Hum Nutr Diet; 2013 Aug; 26(4):329-39. PubMed ID: 23294025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs.
    Derks TGJ; Rodriguez-Buritica DF; Ahmad A; de Boer F; Couce ML; Grünert SC; Labrune P; López Maldonado N; Fischinger Moura de Souza C; Riba-Wolman R; Rossi A; Saavedra H; Gupta RN; Valayannopoulos V; Mitchell J
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of raw starches in the treatment of type I glycogenosis.
    Sidbury JB; Chen YT; Roe CR
    Arch Intern Med; 1986 Feb; 146(2):370-3. PubMed ID: 3456223
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    Am J Clin Nutr; 1997 May; 65(5):1507-11. PubMed ID: 9129484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib.
    Correia CE; Bhattacharya K; Lee PJ; Shuster JJ; Theriaque DW; Shankar MN; Smit GP; Weinstein DA
    Am J Clin Nutr; 2008 Nov; 88(5):1272-6. PubMed ID: 18996862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen storage disease type I: clinical and laboratory profile.
    Santos BL; Souza CF; Schuler-Faccini L; Refosco L; Epifanio M; Nalin T; Vieira SM; Schwartz IV
    J Pediatr (Rio J); 2014; 90(6):572-9. PubMed ID: 25019649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease.
    Weinstein DA; Wolfsdorf JI
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S35-9. PubMed ID: 12373568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthotopic liver transplantation for type I glycogenosis unresponsive to medical therapy.
    Sokal EM; Lopez-Silvarrey A; Buts JP; Otte JB
    J Pediatr Gastroenterol Nutr; 1993 May; 16(4):465-7. PubMed ID: 8315558
    [No Abstract]   [Full Text] [Related]  

  • 14. Sleep and quality of life of patients with glycogen storage disease on standard and modified uncooked cornstarch.
    Rousseau-Nepton I; Huot C; Laforte D; Mok E; Fenyves D; Constantin E; Mitchell J
    Mol Genet Metab; 2018 Mar; 123(3):326-330. PubMed ID: 29223626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose therapy for glycogenosis type 1 in infants: comparison of intermittent uncooked cornstarch and continuous overnight glucose feedings.
    Wolfsdorf JI; Keller RJ; Landy H; Crigler JF
    J Pediatr; 1990 Sep; 117(3):384-91. PubMed ID: 2202802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type I glycogenosis: extending therapy with uncooked cornstarch].
    Biggemann B; Hilgarth R; Wendel U
    Monatsschr Kinderheilkd; 1986 Mar; 134(3):142-5. PubMed ID: 3084952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilization of cornstarch in glycogen storage disease type Ia.
    Bodamer OA; Feillet F; Lane RE; Lee PJ; Dixon MA; Halliday D; Leonard JV
    Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1251-6. PubMed ID: 12439121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, blinded trial of uncooked cornstarch to diminish nocturnal hypoglycemia at diabetes camp.
    Kaufman FR; Halvorson M; Kaufman ND
    Diabetes Res Clin Pract; 1995 Dec; 30(3):205-9. PubMed ID: 8861460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Description of a case of type I glycogenosis treated with diazoxide].
    Gardoni L; Giranzani F
    Minerva Pediatr; 1978 Oct; 30(19):1535-42. PubMed ID: 279797
    [No Abstract]   [Full Text] [Related]  

  • 20. Cornstarch requirements of the adult glycogen storage disease Ia population: A retrospective review.
    Dahlberg KR; Ferrecchia IA; Dambska-Williams M; Resler TE; Ross KM; Butler GL; Kuo CL; Ryan PT; Weinstein DA
    J Inherit Metab Dis; 2020 Mar; 43(2):269-278. PubMed ID: 31415093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.